Tower Research Capital LLC (Trc) Alpha Teknova, Inc. Transaction History

Tower Research Capital LLC (Trc)

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.29 - $2.81 $1,873 - $4,080	1,452 Added 21.92%	8,075 $11,000
Q1 2024 May 15, 2024	BUY	$2.41 - $3.88 $8,447 - $13,599	3,505 Added 112.41%	6,623 $17,000
Q4 2023 Feb 13, 2024	SELL	$1.85 - $3.73 $1,613 - $3,252	-872 Reduced 21.85%	3,118 $11,000
Q3 2023 Nov 14, 2023	SELL	$1.66 - $3.83 $828 - $1,911	-499 Reduced 11.12%	3,990 $11,000
Q2 2023 Aug 14, 2023	BUY	$1.8 - $3.98 $1,580 - $3,494	878 Added 24.31%	4,489 $11,000
Q1 2023 May 09, 2023	SELL	$2.74 - $6.25 $16,672 - $38,031	-6,085 Reduced 62.76%	3,611 $10,000
Q4 2022 Feb 10, 2023	SELL	$3.23 - $5.64 $7,939 - $13,863	-2,458 Reduced 20.22%	9,696 $55,000
Q3 2022 Nov 10, 2022	BUY	$3.34 - $9.2 $36,208 - $99,737	10,841 Added 825.67%	12,154 $40,000
Q2 2022 Aug 15, 2022	SELL	$6.39 - $16.24 $242 - $617	-38 Reduced 2.81%	1,313 $11,000
Q1 2022 May 12, 2022	SELL	$12.79 - $21.64 $972 - $1,644	-76 Reduced 5.33%	1,351 $19,000
Q4 2021 Feb 14, 2022	BUY	$17.49 - $26.72 $19,991 - $30,540	1,143 Added 402.46%	1,427 $29,000
Q3 2021 Nov 15, 2021	BUY	$17.47 - $27.49 $4,961 - $7,807	284 New	284 $7,000

5.4M

Ticker TKNO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 28,080,500
Market Cap $217M
Description
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; ...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.